Updates
Perspectives and deep dives on the models powering AI for life science discovery.
Updates
This update enables computational biologists and medicinal chemists to rapidly predict 3D biomolecular structures and binding affinities through a streamlined workflow on Vecura, eliminating the need for complex, manual infrastructure setup.
Updates
This update enables antibody researchers and protein engineers to streamline sequence analysis and design through a guided, no-code workflow on Vecura, eliminating the need to manage complex local model infrastructure.
Updates
This update enables structural biologists and protein engineers to rapidly predict 3D protein structures through a streamlined workflow on Vecura, eliminating the need for complex MSA-based computational pipelines.
Updates
Antibody researchers can now generate diverse, structurally-compatible antibody sequences directly within Vecura using the AntiDIF model, bypassing the need for complex local infrastructure setup.
Updates
This update enables computational biologists and drug discovery researchers to predict protein-ligand binding poses and affinity directly through a guided workflow on Vecura, eliminating the need to manage complex, resource-intensive infrastructure.
Updates
This update allows structural biologists and protein engineers to perform sophisticated all-atom protein complex design and folding directly within Vecura, eliminating the need to manage complex GPU-intensive infrastructure.
Updates
This update enables researchers and drug discovery scientists to generate high-resolution 3D protein structures directly within the Vecura platform, streamlining structural biology workflows without the burden of managing complex computational infrastructure.
Updates
This update empowers protein engineers and computational biologists to prioritize high-potential mutation candidates through a guided, zero-shot workflow on Vecura, eliminating the need for complex infrastructure or multiple-sequence alignment.
Updates
This update enables protein engineers and computational biologists to design and score antibody and nanobody sequences through a guided, accessible workflow inside Vecura, eliminating the need for complex technical infrastructure.